Pierpaolo Correale a, b, Francesca Pentimalli c, Valerio Nardone d , Antonio Giordano b, e, Luciano Mutti b, f
a Medical Oncology Unit, Grand Metropolitan Hospital “Bianchi-Melacrino-Morelli”, Reggio Calabria, Italy
b Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA
c Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G Pascale, Naples, Italy
d Department of Precision Oncology, University Hospital of Campania “L Vanvitelli”, Naples 80138, Italy
e Department of Medical Biotechnologies, University of Siena, Siena, Italy
f Italian Group for Research and Therapy for Mesothelioma (GIMe), Voghera, Italy